疫苗市场增长、规模、份额、趋势、关键参与者分析及 2030 年预测

  • Report Code : TIPRE00015468
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Vaccines Market Growth Report | Global Size, Share & Future Outlook

Buy Now

【研究报告】疫苗市场规模预计将从2022年的1352.8亿美元增长到2030年的2163.0亿美元;预计 2022 年至 2030 年该市场的复合年增长率为 6.0%。
分析师的观点
疫苗市场分析解释了市场驱动因素,例如传染病流行率上升以及 COVID-19 期间疫苗使用量的增加大流行。此外,疫苗开发的创新预计将在预测期内引入新的市场趋势。根据类型,市场分为减毒活疫苗、灭活疫苗、类毒素疫苗、亚单位和结合疫苗等。减毒活疫苗细分市场在 2022 年占据最大的市场份额。根据应用,疫苗市场分为人乳头瘤病毒 (HPV)、癌症、MMR、DPT 等。 2022 年,HPV 细分市场占据最大市场份额。按给药途径,疫苗市场分为口服、鼻腔和注射。注射剂细分市场将在 2022 年占据最大的市场份额。按年龄划分,在 2022 年至 2030 年的预测期内,儿科细分市场将在全球疫苗市场中占据更大份额。从最终用户来看,疫苗接种中心和项目部分将在 2022 年至 2030 年期间占据全球疫苗市场的最大份额。
疫苗是一种生物制剂,可为特定传染病或恶性疾病提供主动获得性免疫力。疫苗制剂通常含有与致病微生物类似的试剂,通常由微生物、毒素或其表面蛋白之一的弱化或灭活形式制成。疫苗可以是预防性的,也可以是治疗性的。
市场洞察
传染病不断上升
根据康涅狄格州公共卫生部2020年报告,康涅狄格州2020年记录的传染病病例数如下。
2020 年康涅狄格州报告疾病病例
疾病
总数
甲型肝炎
15
流感
98
疟疾
4
结核
>54
SARS-CoV-2
200,379
来源:Insight Partners 分析
此外,下表显示了卫生防护中心 2020 年报告中的值得注意的传染病:
值得注意传染病
疾病
总数
SARS-CoV-2
8,847
水痘
1,987
社区相关耐甲氧西林金黄色葡萄球菌感染
813
登革热发烧
22
结核病
3,656
资料来源:Insight Partners 分析
在所有传染病中,SARS-CoV-2 在 2020 年至 2022 年期间创下历史新高,而其他疾病的发病率则最高登革热、水痘、结核病等疫苗的接种率很低。然而,由于全球病例不断增加,SARS-CoV-2 疫苗的使用率很高。根据 2021 年发布的英国公共卫生报告,英国 12 个月的 DTaP/IPV/Hib/HepB3 疫苗接种覆盖率增加了 0.1% 至 92.2%,轮状病毒疫苗接种率增加了 0.3% 至 90.6%。但MenB2较上年下降0.1%,占比为92.3%。此外,英国 NHS 报告显示,2022 年 12 月,所有成人护理院居民中共有 88.9% 的人接种了 COVID-19 加强剂疫苗。因此,由于传染病发病率上升,疫苗接种需求较高,导致整体市场增长。
市场趋势
疫苗开发创新
全球疫苗开发可能因COVID-19 大流行加速了技术的采用。例如,mRNA疫苗创新和新的给药方法(包括鼻内给药)是最具创新性的疫苗开发方法。此外,制造商正在尝试不同的方法来改进这些疫苗,并以提高疫苗生产效率、增强免疫原性、耐久性和整体功效的方式提供疫苗。
此外,更加简化的监管流程和临床试验方案的标准化也发挥了重要作用。在将 COVID-19 疫苗的疫苗开发时间从 10 年缩短到 260 天方面发挥着至关重要的作用,这是疫苗开发创新的另一个例子。这种创新的疫苗输送方法和有利的疫苗开发创新是 2022-2030 年预测期间市场增长的原因。

报告细分和范围
市场机会
治疗性疫苗开发
传统疫苗刺激针对病毒和细菌等特定病原体的抗体和免疫蛋白的产生。同样,治疗性疫苗会刺激免疫系统瞄准癌细胞并控制艾滋病毒等慢性感染的进展。此外,治疗性疫苗通常会刺激接受者的免疫系统以减缓或阻止慢性疾病进展或靶向癌细胞。此外,用于治疗非传染性疾病的治疗性疫苗涵盖多种可能的制剂、抗原和作用机制。因此,治疗性疫苗的开发将为 2022-2030 年的预测提供利润丰厚的市场机会。
正在开发的治疗性疫苗示例
适应症
开发阶段
卵巢癌
第 1 阶段
多种骨髓瘤
1 期
1 型糖尿病
临床前
急性髓性白血病
3
间皮瘤
2
来源:Insight Partners 分析
基于类型的见解
根据类型,疫苗市场分为减毒活疫苗、灭活疫苗、类毒素疫苗、亚单位和结合疫苗等。减毒活疫苗细分市场在 2022 年占据最大的市场份额。减毒活疫苗是用于预防多种疾病的非常有效的疫苗,包括流感、水痘、麻疹、脊髓灰质炎和结核病。据世界卫生组织(WHO)报告,季节性流感病例近10亿例,其中重症病例500万例。此外,它每年导致约 290,000 至 650,000 人因呼吸系统死亡。事实证明,减毒活流感疫苗(LAIV)在对抗人群感染方面具有优势。例如,LAIV 可以为 65 岁以下的成年人提供高达 90% 的保护,为 65 岁以上的成年人提供高达 40% 的保护。上述因素是 2022-2030 年预测期内该细分市场市场增长的原因。< br>基于应用的见解
根据应用,疫苗市场分为人乳头瘤病毒(HPV)、癌症、MMR、DPT 等。 2022 年,HPV 细分市场占据最大的市场份额。根据 WHO 报告,HPV 在撒哈拉以南非洲地区的女性中高度流行(24%),其次是拉丁美洲和加勒比地区(16%)、东欧(14%) )和东南亚(14%)。此外,全球每年有 625,600 名女性和 694,000 名男性患有 HPV 相关癌症。此外,到 2020 年,宫颈癌占女性 HPV 相关癌症的 93%。因此,由于病例不断增加,人们对 HPV 疫苗的需求很高,因为这些疫苗可以预防尖锐湿疣和大多数宫颈癌。此外,HPV疫苗得到了美国食品和药物管理局(USFDA)的高度认可。 “GARDASIL 9”就是美国 FDA 批准的 HPV 疫苗的一个例子。上述因素是 2022 年至 2030 年预测期内该细分市场市场增长的原因。
基于给药途径的见解
就给药途径而言,疫苗市场分为口服、鼻腔、并可注射。注射剂细分市场在 2022 年占据最大市场份额。最常见的疫苗接种途径是注射剂,因为通过皮下或皮内途径注射疫苗可能会导致局部刺激、皮肤变色、炎症等。
此外,CDC 报告显示 DTaP、DT、HepA、HepB、Hib、HPV、IIV4、RIV4、ccIIV4、IPV*†、MenACWY、MenB、MMR‡、PCV13、PPSV23*†、RZV、Td、Tdap、TT 、VAR† 是通过注射给药途径施用的常见疫苗。通过注射途径注射的各种疫苗是 2022 年至 2030 年预测期内该细分市场市场增长的独立因素。
手术导航系统市场,按类型 – 2022 年和 2030 年
区域分析
北美占据疫苗市场的最大份额。北美市场细分为美国、加拿大和墨西哥。美国占据该地区疫苗市场的最大份额。
政府对疫苗开发的支持不断增加,仅提高了美国的疫苗产量。例如,2023年3月,美国政府宣布投资319亿美元用于mRNA疫苗研究和采购。疫苗研究基于对美国政府研究拨款以及与 mRNA 疫苗和技术相关的采购合同的广泛分析。疫情发生后,美国公共资金的292亿美元(92%)宣布用于疫苗采购,其中22亿美元(7%)支持临床试验,1.08亿美元支持制造和科学。此外,美国公司的疫苗获得了有利的批准。例如,2023年9月,辉瑞和BioNTech宣布获得美国FDA批准的“补充生物制品许可申请(COMIRNATY 2023-2024配方)”,适用于12岁及以上的个人,并具有六个月的紧急使用授权(EUA)。新批准的疫苗可在美国各地的药房、医院和诊所购买。快速批准以及政府对疫苗开发和制造支持的增加是美国在该区域市场中占据主要市场份额的原因。
预计亚太地区将成为全球疫苗市场中复合年增长率最高的地区。亚太地区在研发支出中所占份额最大,在疫苗研发 (R&D) 方面拥有大量出版物和专利。此外,该地区也是国有和私营制药公司以及进行疫苗研发的合同研究组织 (CRO) 的所在地。此外,亚太地区国家利用多种供应方和需求方方法来激励疫苗研发投资。例如,亚太地区的高收入国家是产品开发合作伙伴关系的主要贡献者,这些国家推出了疫苗开发计划,以促进创新的疫苗生产和研究。
在 COVID-19 大流行期间,亚太地区的许多高收入和中等收入国家建立了疫苗开发计划。疫苗开发生产设施。亚太地区机构和政府间组织帮助促进和协调疫苗研发区域合作。因此,亚太地区开展疫苗开发计划以促进创新疫苗生产和研究活动的有利政策是导致 2022-2030 年疫苗市场复合年增长率最高的一个独立因素。
该报告介绍了该地区运营的领先企业全球疫苗市场。其中包括葛兰素史克、辉瑞、赛诺菲、默克、印度血清研究所 (SII)、阿斯利康、BioNTech、Biological E、科兴、国药和巴拉特生物技术。 2022年8月,葛兰素史克宣布收购Affinivax, Inc.,旨在建立强大的专科药物和疫苗产品组合。此次收购包括下一代 24 价肺炎球菌疫苗,该疫苗目前正处于第二阶段开发,基于高度创新的多抗原呈递系统 (MAPS) 平台技术。 MAPS 技术支持比传统接合技术更高的效价,并且针对流行的肺炎球菌血清型的覆盖范围较小。与目前的肺炎球菌疫苗相比,它对许多个体血清型产生更高的抗体反应。
2022 年 1 月,辉瑞公司宣布与 BioNTech 合作进行新的研究、开发和商业化,开发一种潜在的第一种基于 mRNA 的疫苗,用于预防肺炎球菌疫苗。带状疱疹。此外,此次合作还建立在该公司成功开发第一个经批准且使用最广泛的 mRNA 疫苗以帮助预防 COVID-19 的基础上。
公司简介
GSKPfizer赛诺菲默克印度血清研究所 (SII)阿斯利康 BioNTechBiological ESinovacSinopharmBharat Biotech
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are vaccines?

A vaccine is a biological preparation that provides active acquired immunity against a particular disease. A vaccine consists of an agent that resembles or is a part of the disease-causing microorganism and is often made from weakened or killed forms of the microorganism, its toxins, or one of its surface proteins. The agent triggers the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.

Who are the major players in the vaccine market?

Pfizer Inc., GlaxoSmithKline plc, Merck & Co. Inc, Sanofi, Johnson & Johnson Services, Inc., Panacea Biotec Limited, Astellas Pharma Inc., NOVAVAX, INC., VBI Vaccines Inc., and Bavarian Nordic are some of the major players in the vaccines market.

What are the driving factors for the vaccines market across the globe?

The growth of the market is attributed to the rising prevalence of infectious diseases, growing focus on implementation of immunization programs, and increasing support for vaccine development.

The List of Companies - Vaccines Market

  1. GSK
  2. Pfizer
  3. Sanofi
  4. Merck
  5. Serum Institute of India (SII)
  6. AstraZeneca
  7. BioNTech
  8. Biological E
  9. Sinovac
  10. Sinopharm
  11. Bharat Biotech

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..